PRIVATE-LABEL LOPERAMIDE ENCROACHING ON OTC ANTIDIARRHEAL MARKET
This article was originally published in The Tan Sheet
Executive Summary
PRIVATE-LABEL LOPERAMIDE ENCROACHING ON OTC ANTIDIARRHEAL MARKET, accounting for the majority of the 8.7% share of the market held by private-label antidiarrheals during the 12 months through February 1994, according to Information Resources, Inc. subsidiary Towne-Oller & Associates. The 8.7% share represents an increase of more than 6 share points from the 2% market share held by private-label antidiarrheals in the previous 12-month period.